Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2012-12-11 17:20:14
Reporting Period:
Filing Date:
Accepted Time:
2012-12-11 17:20:14
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1360886 Osiris Therapeutics Inc. OSIR Biological Products, (No Disgnostic Substances) (2836) 710881115
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1398249 Leroux Michelle Williams 7015 Albert Einstein Drive
Columbia MD 21046
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-12-11 520 $0.40 520 No 4 P Direct
Common Stock Disposition 2012-12-11 520 $9.31 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Options, right to buy Disposition 2012-12-11 520 $0.40 520 $0.40
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
168,250 2003-04-08 2013-04-08 No 4 M Direct
  1. Represents the cashless exercise of incentive stock options to purchase common stock that were secheduled to expire in April 2013.